Why these 4 ASX shares have jumped higher today

In afternoon trade the S&P/ASX 200 (Index: ^AXJO) (ASX: XJO) is down 0.4% to 5,781 points due largely to declines in the banking sector following Moody’s decision to downgrade the banks.

Four shares which have gone against the grain and climbed higher are listed below. Here’s why they have posted gains:

The Bubs Australia Ltd (ASX: BUB) share price has continued to climb higher for a second day in a row. Today the infant formula and baby food company’s shares are up 14% to 20 cents. Investors have been fighting to get hold of the company’s shares since it announced a strategic partnership with NetEase I believe it is a very positive development and can’t say I’m surprised by the buying frenzy.

The Compumedics Limited (ASX: CMP) share price has gone gangbusters today and rocketed 43% to 53 cents. This morning the medical device company announced a major contract with Barrow Neurological Institute in the United States. This led Moelis Australia to upgrade its shares to a buy rating with a 58 cents price target.

The Independence Group NL (ASX: IGO) share price has jumped 7% to $3.38 despite there being no significant news out of the gold miner. One piece of news out this morning, though, was that major shareholder T. Rowe Price has increased its stake in the company to over 8.2%.

The Yowie Group Ltd (ASX: YOW) share price is up 8% to 32.5 cents. This is the second day in a row that the confectionery company’s shares have rallied higher despite there being no news out of it. But with its shares down by 50% year-to-date, I feel this recent rally could be attributable to bargain hunters swooping in.

If you missed out on gains today then don't worry. These growth shares could be next in line to surge higher if you ask me.

Top 3 ASX Blue Chips To Buy In 2017

For many, blue chip stocks mean stability, profitability and regular dividends, often fully franked..

But knowing which blue chips to buy, and when, can be fraught with danger.

The Motley Fool's in-house analyst team has poured over thousands of hours worth of proprietary research to bring you the names of "The Motley Fool's Top 3 Blue Chip Stocks for 2017."

Each one pays a fully franked dividend. Each one has not only grown its profits, but has also grown its dividend. One increased it by a whopping 33%, while another trades on a grossed up (fully franked) dividend yield of almost 7%.

The names of these Top 3 ASX Blue Chips are included in this specially prepared free report. But you will have to hurry. Depending on demand - and how quickly the share prices of these companies moves - we may be forced to remove this report.

Click here to claim your free report.

Motley Fool contributor James Mickleboro has no position in any stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

Two New Stock Picks Every Month!

Not to alarm you, but you’re about to miss a very important event! Chief Investment Advisor Scott Phillips and his team at Motley Fool Share Advisor are about to reveal their latest official stock recommendation. The premium “buy alert” will be unveiled to members and you can be among the first to act on the tip.

Don’t let this opportunity pass you by – this is your chance to get in early!

Simply enter your email now to find out how you can get instant access.

By clicking this button, you agree to our Terms of Service and Privacy Policy. We will use your email address only to keep you informed about updates to our website and about other products and services we think might interest you. You can unsubscribe from Take Stock at anytime. Please refer to our Financial Services Guide (FSG) for more information.